CVE-2024-28117

Public Exploit
Grav vulnerable to Server Side Template Injection (SSTI)

Description

Grav is an open-source, flat-file content management system. Prior to version 1.7.45, Grav validates accessible functions through the Utils::isDangerousFunction function, but does not impose restrictions on twig functions like twig_array_map, allowing attackers to bypass the validation and execute arbitrary commands. Twig processing of static pages can be enabled in the front matter by any administrative user allowed to create or edit pages. As the Twig processor runs unsandboxed, this behavior can be used to gain arbitrary code execution and elevate privileges on the instance. Upgrading to patched version 1.7.45 can mitigate this issue.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.36%
Vendor Advisory github.com
Affected: getgrav grav
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-28117?
CVE-2024-28117 has been scored as a high severity vulnerability.
How to fix CVE-2024-28117?
To fix CVE-2024-28117, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-28117 being actively exploited in the wild?
It is possible that CVE-2024-28117 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-28117?
CVE-2024-28117 affects getgrav grav.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.